Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins
Technology in Cancer Research & Treatment · 2024-01 · 23
DOI: 10.1177/15330338241281285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 09.09.2024. Verfasst von Weijia Kong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glucuronidase, Biomarkers, Tumor, CTLA-4 Antigen, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates various biological processes related to tumor progression. We explore the prognostic value of HPSE and its relationship with immunotherapy response in patients with breast cancer, to improve the effectiveness of immunotherapy and increase the survival outcomes.
Methods
In the study, we explored the prognostic value of HPSE through the The Cancer Genome Atlas (TCGA) database. By using the single-sample gene set enrichment analysis (ssGSEA) method, we measured the infiltration levels of 24 immune cell types in the tumor microenvironment. Cancer Therapeutics Response Portal (CTRP) and PRISM datasets provide the area under the dose-response curve (AUC) to measure drug sensitivity. Using nomograms, we predicted overall survival ability. In vivo studies, we investigated the relationship between HPSE and immune checkpoint proteins and pro-inflammatory cytokines by immunohistochemistry of Triple-Negative Breast Cancer tumors in mice.
Results
Our model demonstrated that the integrating of HPSE with the clinical stage effectively predicts patients’ survival time, highlighting high HPSE expression as a prognostic risk factor for breast cancer. Then the Receiver Operating Characteristic (ROC) curve [AUC of 1 year = 0.747, AUC of 3 years = 0.731] and Decision Curve Analysis (DCA) curve illustrated the satisfactory discriminative capacity of our model, emphasizing its valuable clinical applicability. Immune-related results showed that HPSE correlates strongly with immune infiltrating cells, immune-related genes, and the anti-cancer immunity cycle. In vivo studies have demonstrated that HPSE in breast cancer is associated with increased expression of immune checkpoint proteins CD274 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and is positively correlated with the pro-inflammatory cytokine TNF-α. Meanwhile, we analyzed the 11 types of drugs that are sensitive to the HPSE gene.
Conclusion
Our results show that HPSE can serve as an effective biomarker to predict the prognosis of breast cancer patients and reflect the impact of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- Graduate School, Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Xiaomin Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kong, W., Zhang, G., Wang, Y., Zhang, J., Ding, T., Chen, D., Pan, Y., Yi, R., Yin, X., & Wang, X. (2024). Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241281285
Vancouver
Kong W, Zhang G, Wang Y, Zhang J, Ding T, Chen D, et al. Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241281285
BibTeX
@article{Kong2024,
author = {Kong, Weijia and Zhang, Ganlin and Wang, Yue and Zhang, Jiahui and Ding, Tongjing and Chen, Dong and Pan, Yuancan and Yi, Runxi and Yin, Xiaohui and Wang, Xiaomin},
title = {Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
volume = {23},
doi = {10.1177/15330338241281285}
}
EUVIMED